Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
Blocking the B-cell receptor (BCR) with ibrutinib and other BTKi drugs has revolutionized care in CLL. PI3K inhibitors also block that same receptor and are remarkably effective in treating CLL. Join Dr. Ian Flinn who will explain how these treatments work, the common side effects, and what role they might play in the future.
Join CLL Society and Dr. Susan Leclair for this valuable webinar. You will learn how to interpret your blood test results and gain a better understanding of why they are critical to track in CLL. Dr. Leclair will explain what information in these reports are the most important, discuss how blood results can constantly change, and provide explanations as to why.
COVID-19 Protection for CLL Patients Is Possible, But It May Not Be Available. CLL Society is sharing a series of articles addressing the issue of CLL patients being vaccinated, but still unprotected, and sometimes unaware of their continued risk.
Recorded May 27, 2021 Download Slides https://youtu.be/67E0d2ZPHP0 Welcome: Patty Koffman Co-Founder and Communications Director CLL Society Moderator: Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd Executive Vice President and Chief Medical
On March 22, 2018, I was an outpatient at the Seattle Cancer Care Alliance where I was transfused with my own T-cells that had been harvested a few weeks earlier, then
CLL Society discovered in December that there was a large variation across the United States in when CLL patients were going to be considered eligible to receive the vaccine according to each individual state’s COVID-19 vaccine distribution plan.
Dr. Brian Koffman interviewed Dr. Krish Patel at ASH 2019, about how our native immune system is excellent at controlling cancer when it is working normally. In CLL, the immune system has become dysregulated and does a poor job controlling cancer. Could modifying the immune system with off-the-shelf bi-specific antibodies repair this problem?
Bispecific Antibodies: what are they and are they the future of treatment for CLL (chronic lymphocytic leukemia)?
Brian Maxson, CLL patient, shares his CLL journey, what’s happened so far and what he’s doing with it.
One click to our most popular content.
